---
title: >-
  Fda Director Steven Hahn After the Fda Granted Emergency Use Authorization for
  the First at-Home Covid-19 Diagnostic Test Available without a Prescription.
slug: 20201215-ellume
_id: legacy-744faf90-1c2d-4186-b6d0-e3269e9843c0
_rev: 7QmxBnVgzphH4dpufNYQpx
type: quick_quotes
draft: false
aliases:
  - article/ellume/
_createdAt: '2020-12-15T21:18:59Z'
_updatedAt: '2021-03-16T12:32:44Z'
date: '2020-12-15T21:18:59+00:00'
weight: 50
is_breaking: false
summary: >-
  FDA Director Steven Hahn after the FDA granted emergency use authorization for
  the first at-home COVID-19 diagnostic test available without a prescription.
featured_quote:
  quote: >-
    By authorizing a test for over- the-counter use, the FDA allows it to be
    sold in places like drug stores, where a patient can buy it, swab their
    nose, run the test and find out their results in as little as 20 minutes.
  citation: >-
    FDA Director Steven Hahn after the FDA granted emergency use authorization
    for the first at-home COVID-19 diagnostic test available without a
    prescription.

---
* The nasal swab test by Australian manufacturer Ellume delivers results **via an app on your phone** and is expected to cost [$30](https://apnews.com/article/over-the-counter-home-coronavirus-test-ac070f4d42d9d7eacc486c9bed4ccaa0).
* Unlike the other [225+](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic) COVID-19 diagnostic tests approved this year by the FDA, Ellume’s is available **over-the-counter**.
* Last week, [Ellume](https://www.ellumehealth.com/2020/12/10/ellumes-covid-19-home-test-shows-96-accuracy-in-multi-site-us-clinical-study/) requested emergency use authorization from the FDA and submitted the results of a study conducted in five states involving nearly 200 participants ages 2 to 82.
* According to the [FDA](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic), the Ellume test “correctly identified 96% of positive samples and 100% of negative samples in individuals with symptoms. In people without symptoms, the test correctly identified 91% of positive samples and 96% of negative samples. Ellume, the test correctly.”
* Ellume [says](https://www.ellumehealth.com/2020/12/10/ellumes-covid-19-home-test-shows-96-accuracy-in-multi-site-us-clinical-study/) it plans to ship more than 100,000 tests per day over the next month, and deliver 20 million within the U.S. during the first half of 2021.an 100,000 tests per day over the next month, and deliver 20 million within the U.S. during the first half of 2021.